1. Home
  2. Pharma & Healthcare
  3. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publication Month: Feb 2023 | No. of Pages: 97 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Intravenous cytomegalovirus immunoglobulin (human) is used to prevent cytomegalovirus disease associated with kidney, lung, liver, pancreas, and heart transplantation. Prophylactic CMV-IGIV should be used in combination with ganciclovir in transplants of these organs other than the kidneys of CMV seropositive donors into seronegative recipients.
According to our (Global Info Research) latest study, the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Units), 2018-2029
Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Units), 2018-2029
Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Units), 2018-2029
Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Units), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Biotest, Beijing Tiantan Biological Products, Taibang Biologic Group and Shanxi Kangbao Biological Product. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
25 ml
50 ml
100 ml
Market segment by Application
Hopistial
Clinic
Others
Major players covered
CSL
Biotest
Beijing Tiantan Biological Products
Taibang Biologic Group
Shanxi Kangbao Biological Product
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), with price, sales, revenue and global market share of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) from 2018 to 2023.
Chapter 3, the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV).
Chapter 14 and 15, to describe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
1.1 Product Overview and Scope of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 25 ml
1.3.3 50 ml
1.3.4 100 ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hopistial
1.4.3 Clinic
1.4.4 Others
1.5 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size & Forecast
1.5.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity (2018-2029)
1.5.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
2.1.4 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Recent Developments/Updates
2.2 Biotest
2.2.1 Biotest Details
2.2.2 Biotest Major Business
2.2.3 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
2.2.4 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biotest Recent Developments/Updates
2.3 Beijing Tiantan Biological Products
2.3.1 Beijing Tiantan Biological Products Details
2.3.2 Beijing Tiantan Biological Products Major Business
2.3.3 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
2.3.4 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing Tiantan Biological Products Recent Developments/Updates
2.4 Taibang Biologic Group
2.4.1 Taibang Biologic Group Details
2.4.2 Taibang Biologic Group Major Business
2.4.3 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
2.4.4 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Taibang Biologic Group Recent Developments/Updates
2.5 Shanxi Kangbao Biological Product
2.5.1 Shanxi Kangbao Biological Product Details
2.5.2 Shanxi Kangbao Biological Product Major Business
2.5.3 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
2.5.4 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Shanxi Kangbao Biological Product Recent Developments/Updates
3 Competitive Environment: Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Manufacturer
3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Manufacturer (2018-2023)
3.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturer Market Share in 2022
3.4.2 Top 6 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturer Market Share in 2022
3.5 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market: Overall Company Footprint Analysis
3.5.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market: Region Footprint
3.5.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market: Company Product Type Footprint
3.5.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Region
4.1.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2018-2029)
4.1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2018-2029)
4.1.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Region (2018-2029)
4.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029)
4.3 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029)
4.4 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029)
4.5 South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029)
4.6 Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2029)
5.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Type (2018-2029)
5.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2029)
6.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Application (2018-2029)
6.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Application (2018-2029)
7 North America
7.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2029)
7.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2029)
7.3 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
7.3.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2018-2029)
7.3.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2029)
8.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2029)
8.3 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
8.3.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2018-2029)
8.3.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Region
9.3.1 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2029)
10.2 South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2029)
10.3 South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
10.3.1 South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2018-2029)
10.3.2 South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
11.3.1 Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Drivers
12.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Restraints
12.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)
13.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Production Process
13.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Typical Distributors
14.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Tables and Figures

List of Tables
Table 1. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
Table 6. CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity (K Units), Average Price (US$/Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Recent Developments/Updates
Table 8. Biotest Basic Information, Manufacturing Base and Competitors
Table 9. Biotest Major Business
Table 10. Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
Table 11. Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity (K Units), Average Price (US$/Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Biotest Recent Developments/Updates
Table 13. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Tiantan Biological Products Major Business
Table 15. Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
Table 16. Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity (K Units), Average Price (US$/Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beijing Tiantan Biological Products Recent Developments/Updates
Table 18. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
Table 19. Taibang Biologic Group Major Business
Table 20. Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
Table 21. Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity (K Units), Average Price (US$/Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Taibang Biologic Group Recent Developments/Updates
Table 23. Shanxi Kangbao Biological Product Basic Information, Manufacturing Base and Competitors
Table 24. Shanxi Kangbao Biological Product Major Business
Table 25. Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product and Services
Table 26. Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity (K Units), Average Price (US$/Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Shanxi Kangbao Biological Product Recent Developments/Updates
Table 28. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Manufacturer (2018-2023) & (US$/Units)
Table 31. Market Position of Manufacturers in Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Production Site of Key Manufacturer
Table 33. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market: Company Product Type Footprint
Table 34. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market: Company Product Application Footprint
Table 35. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) New Market Entrants and Barriers to Market Entry
Table 36. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Region (2018-2023) & (US$/Units)
Table 42. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Region (2024-2029) & (US$/Units)
Table 43. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Type (2018-2023) & (US$/Units)
Table 48. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Type (2024-2029) & (US$/Units)
Table 49. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2023) & (K Units)
Table 50. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2024-2029) & (K Units)
Table 51. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Application (2018-2023) & (US$/Units)
Table 54. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Application (2024-2029) & (US$/Units)
Table 55. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2023) & (K Units)
Table 56. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2024-2029) & (K Units)
Table 57. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2023) & (K Units)
Table 58. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2024-2029) & (K Units)
Table 59. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2023) & (K Units)
Table 66. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2024-2029) & (K Units)
Table 67. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2023) & (K Units)
Table 72. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2024-2029) & (K Units)
Table 73. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2023) & (K Units)
Table 74. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2024-2029) & (K Units)
Table 75. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2023) & (K Units)
Table 80. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2024-2029) & (K Units)
Table 81. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2023) & (K Units)
Table 82. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2024-2029) & (K Units)
Table 83. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2018-2023) & (K Units)
Table 88. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Type (2024-2029) & (K Units)
Table 89. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Raw Material
Table 96. Key Manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Raw Materials
Table 97. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Typical Distributors
Table 98. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Typical Customers
List of Figures
Figure 1. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Picture
Figure 2. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Type in 2022
Figure 4. 25 ml Examples
Figure 5. 50 ml Examples
Figure 6. 100 ml Examples
Figure 7. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Application in 2022
Figure 9. Hopistial Examples
Figure 10. Clinic Examples
Figure 11. Others Examples
Figure 12. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price (2018-2029) & (US$/Units)
Figure 16. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Type (2018-2029) & (US$/Units)
Figure 31. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Application (2018-2029) & (US$/Units)
Figure 34. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Region (2018-2029)
Figure 54. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Drivers
Figure 75. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Restraints
Figure 76. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) in 2022
Figure 79. Manufacturing Process Analysis of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)
Figure 80. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source




Companies Mentioned
CSL
Biotest
Beijing Tiantan Biological Products
Taibang Biologic Group
Shanxi Kangbao Biological Product

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets